Signaling of angiotensin II-induced vascular protein synthesis in conduit and resistance arteries in vivo

BMC Cardiovascular Disorders

Volumn 4, Issue , 2004, Pages

  Daigle, Christine ^a   Martens, Fabrice M A C ^a   Girardot, Daphné ^a   Dao, Huy Hao ^a   Touyz, Rhian M ^b   Moreau, Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Conduit arteries; ERK 1 2; Rapamycin; Remodeling; Resistance arteries

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; IRBESARTAN; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RAPAMYCIN; ANGIOTENSIN II; BIPHENYL DERIVATIVE; FLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERIAL PRESSURE; ARTICLE; CHEMICAL LABELING; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEMODYNAMIC PARAMETERS; IN VIVO STUDY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; ANIMAL; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA; BIPHENYL COMPOUNDS; BLOOD PRESSURE; FLAVONOIDS; LEUCINE; MALE; MESENTERIC ARTERIES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SIROLIMUS; TETRAZOLES;

EID: 3042598994     PISSN: 14712261     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2261-4-6     Document Type: Article

References (34)

1. Geisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured vascular smooth muscle cells. Circulation Research 1988, 62:749-756.
2. Simon G, Illyes G, Csiky B: Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, blood pressure and time. Hypertension 1998, 32:654-660.
3. Moreau P, d'Uscio LV, Takase H, Shaw S, Barton M, Lüscher TF: Angiotensin II increases tissue endothelin and induced vascular hypertrophy in vivo: reversal by ETA-receptor antagonist. Circulation 1997, 96:1593-1597.
4. Griffin SA, Brown WCB, Macpherson F, McGrawth JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991, 17:626-635.
5. Kato H, Hou J, Chobanian AV, Brecher P: Effects of angiotensin II infusion and inhibition of nitric oxyde synthase on the rat aorta. Hypertension 1996, 28:153-158.
6. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circulation Research 1991, 68:450-456.
7. Berk BC: Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. Journal of the American Society of Nephrology 1999, 10:S62-S68.
8. Sonenberg N, Gingras AC: The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol 1998, 10:268-275.
9. Servant MJ, Giasson E, Meloche S: Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. Journal of Biological Chemistry 1996, 271:16047-16052.
10. Giasson E, Meloche S: Role of P70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. Journal of Biological Chemistry 1995, 270:5225-5231.
11. Sadoshima J, Izumo S: Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro: potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circulation Research 1995, 77:1040-1052.
12. Tsuda T, Kawahara Y, Ishida Y, M. Koide., K. Shii., Yokoyama M: Angiotensin II stimulates two myelin basic protein/microtubular associated protein 2 kinases in cultured vascular smoothe muscle cells. Circulation Research 1992, 71:620-630.
13. Alessi DR, Cuenda A, Cohen P, Dudley DT, Salteil AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. Journal of Biological Chemistry 1995, 270:27489-27494.
14. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Nat Acad Sci U.S.A 1995, 92:7686-7689.
15. Proud CG: p70 S6 kinase: an enigma with variations. Trends in Biological Sciences 1996, 21:181-185.
16. Moreau P, Lamarche L, K.-Laflamme A, Yamaguchi N, de Champlain J: Chronic hyperinsulinemia and hypertension: the role of the sympathetic nervous system. Journal of Hypertension 1995, 13:333-340.
17. McNulty PH, Young LH, Barrett EJ: Response of the rat heart and skeletal muscle protein in vivo to insulin and amino acid infusion. American Journal of Physiology 1993, 264:E958-E965.
18. Voisin L, Foisy S, Giasson E, Moreau P, Meloche S: EGF receptor transactivation is obligatory for protein synthesisstimulation by G protein-coupled receptors. Am J Physiol Cell Physiol 2002, 83:C446-55.
19. Martens FMAC, Demeilliers B, Girardot D, Daigle C, Dao HH, deBlois D, Moreau P: Vessel specific stimulation of protein synthesis by nitric oxide synthase inhibition: role of extracellular regulated kinases 1/2. Hypertension 2002, 39:16-21.
20. Lowry OH, Rosenbrough NJ, Lewis Far A, Randall RJ: Protein measurement with the folin-phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
21. Touyz RM, Deng LY, He G, Wu HH, Schiffrin EL: Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. Journal of Hypertension 1999, 17:907-916.
22. Su EJ, Lombardi DM, Siegal J, Schwartz SM: Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure. Hypertension 1998, 31:1331-1337.
23. Simon G, Altman S: Subpressor angiotensin II is a bifunctional growth factor of vascular muscle in rats. Journal of Hypertension 1992, 10:1165-1171.
24. Matrougui K, Eskildsen-Helmond A, Fiebeler A, Henrion D, Levy BI, Tedgui A, Mulvany MJ: Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric arteries. Hypertension 2000, 36:617-621.
25. Rao GN, Griendling KK, Frederickson RM, Sonenberg N: Angiotensin II induces phosphorylation of eukaryotic protein synthesis initiation factor 4E in vascular smooth muscle cells. Journal of Biological Chemistry 1994, 269:7180-7184.
26. von Manteuffel SR, Gingras A-C, Ming X-F, Sonenberg N, Thomas G: 4E-BP1 phosphorylation is mediated by the FRAP-p70S6k pathway and is independent of mitogen-activated protein kinase. Proceedings of the National Academy of Science of the USA 1996, 93:4076-4080.
27. Jefferies HBJ, Thomas G: Ribosomal protein S6 phosphorylation and signal transduction. Translational Control Edited by: Hershey JWB, Mathews MB and Sonenberg N. Cold Spring Harbor, Cold Spring Harbor Laboratory Press; 1996:389-410.
28. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, Inagami T: Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. Journal of Biological Chemistry 1999, 274:36843-36851.
29. Herbert JM, Delisee C, Dol F, Schaeffer P, Cazaubon C, Nisato D, Chatelain P: Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro. European Journal of Pharmacology 1994, 251:143-150.
30. Cazaubon C, Gougat J, Bousquet F, Guiraudou P, Gayraud R, Lacour C, Roccon A, Galindo G, Barthelemy G, Gautret B, et al.: Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 1993, 265:826-834.
31. Wu L, Iwai M, Nakagami H, Chen R, Suzuki J, Akishita M, de Gasparo M, Horiuchi M: Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arteriosclerosis, Thrombosis and Vascular Biology 2002, 22:49-54.
32. Cavanaugh JE, Ham J, Hetman M, Poser S, Yan C, Xia Z: Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons. J Neurosci 2001, 21:434-443.
33. Kim S, Murakami T, Izumi Y, Yano M, Miura K, Yamanaka S, Iwao H: Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activities are continuously and differentially increased in aorta of hypertensive rats. Biochemical and Biophysical Research Communications 1997, 236:199-204.
34. Girardot D, Demeilliers B, deBlois D, Moreau P: ERK1/2-mediated vasoconstriction normalizes wall stress in small mesenteric arteries during NOS inhibition in vivo. J Cardiovasc Pharmacol 2003, 42:339-347.